Peer Review History
| Original SubmissionMay 4, 2020 |
|---|
|
PONE-D-20-13116 A Novel Approach to Predicting Exceptional Growth in Research PLOS ONE Dear Dr. Boyack, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 30 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Lutz Bornmann Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for inlcuding your competing interests statement; "The authors have declared that no competing interests exist." We note that one or more of the authors are employed by a commercial company: SciTech Strategies, Inc
Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper presents a study on the development of a method for predicting exceptional growth in research topics, that is, emerging topics. This issue is of high importance to science and technology policy makers, yet there is no widely accepted automatic method available. A clearly raised limitation is that the construction of research communities relies on "future" information in that the clustering of papers uses information only available after publication, namely the citations from later papers. However, this issue is carefully considered in the analysis and the reasons for including the parts of the analysis based on "future" data are sound. Several other concerns are pointed out, such as algorithmic clusters without a specific topic, which are left for future studies. Based on the presented method, the paper also gives a specific prediction on likely candidate emerging topics in AI. This is especially commendable, as it allows independent external validation on whether these topics indeed will show the expected exceptional growth in the years to come Comments: The authors keep using the terms "classification" and "classify" (i.e. page 7, lines 146, 148 and 150), which are not technically the correct terms when clustering is meant. Classification always involves a priori defined classes. p. 13 and 14: The definition of the concepts Forecast Year, Target Year and Peak Year should be given before Publication Share and Growth, as Growth Rate relies on them. Reviewer #2: The following technical concerns should be considered in the revision: - Expost facto perspective: A big problem of such prediction models in bibliometrics is that they are almost always based on given data from the past. It cannot be excluded that the results are based on specific implicit selections in the light of later results. Such selection biases can manifest itself in the choice of the RC cluster solution or the choice of the predictor variables or the choice of parameters in the optimization process. In my opinion, the problem of such potential biases should be formulated at least as a further limitation of the results of the study. One possible argument against it might be the big sample size. - Term “research community” (RC): The term "research community" was adopted by Kuhn. I wonder if a grouping of publications according to keywords, citations and references really reflects what Kuhn understands by a "research community" as a cluster of concept, practices, norms and standards. It would certainly be helpful to include Kuhn's definition of RC in the manuscript or to omit it altogether. - Identification of RC as a black box: The VOS algorithm for identification of RCs and scientific fields is certainly an interesting alternative to journal-based field identification. Nevertheless, it remains unclear, even in this manuscript, what these RCs mean and by which criteria the cluster solution was evaluated. Why 100,000 and not 10,000 RCs. The VOS algorithm is more or less a black box. It would be helpful if the revision could give a little more information about how the RCs came about numerically. As far as I am understand the manuscript correctly the clustering with the VOS algorithm was done for all publications in the respective time frame (e.g., 1996-2012) and not for each year. I wonder whether the clustering might correlate with the frequency pattern of publication. It must be guaranteed that the RCs are independent from the special growth trends over time. - Critical Success Index (CSI) (p.6): The concepts of false positive, false negative... have strong roots in medical diagnostics. Here the concepts of sensitivity (as ability of a test to correctly classify an individual as ill) and specificity (as ability of a test to correctly classify an individual as not healthy) are of central importance. The concept of CSI is similar to, but not identical with the concept of a positive predictive value (PPV), the percentage of patients with a positive test result who are actually ill. I wonder why the manuscript does not use common concepts that have a clear meaning instead of CSI. It is not fully clear, what CSI actually means. It is also not clear what is meant by a "false positive rate of 67%". Have 67% of RCs without exceptional growth been predicted as exceptional growth? - Arbitrary threshold values (p. 15): The manuscript contains a number of thresholds without further explanations. One gets the impression of arbitrarily chosen values. Exceptional growth rate is binary defined with 1 if GR_FY>1.08 and 0 if it does not. Why 8% growth not 5% or 10%? Perhaps, a percentile approach might be more adequate (e.g., in 20% percentile of all RCs). RCs were considered with at least 20 papers, why 20 papers? On page 23 a z-test value of 4.0 (probably based on the standard error of the regression coefficient) was mentioned as a criterion for including a variable in the model (stepwise regression), which is rather high and corresponds to an alpha value that exceeds .0001. This might make sense in the case of these large samples, but there is no explanation for this value in the manuscript. A 3-year forecast was justified because “it may present opportunities for action”. In my view short explanations are necessary to justify these thresholds. - Prediction accuracy: On page 37 it was stated “These four variables very extremely effective in predicting exceptional growth with a pseudo-R2 (28) of 37%”. I constructed a small data example of a 2x2 table (x=binary predictor , y = binary exceptional growth) (50, 10, 10, 50) and calculated a probit regression. The pseudo R_2 was .38 (comparable to the Pseudo-R2 in Table 5). Although this is a strong effect, the corresponding values for sensitivity and specificity are around 83%. These are high values, that’s true, but with a 17% error proportion not an “extremely effective prediction”. The sensitivity of the test for Corona is about .98, the specificity is about .95. With respect to the criteria of publication of PlosOne the following statements can be formulated. The study represents the results of original work. Results reported have not been published elsewhere. Experiments, statistics, and other analyses are performed to a high technical standard, but are not fully described in sufficient detail. Conclusions are presented in an appropriate fashion, but it somewhat questionable, whether the conclusions (predictors) are fully supported by the data. The article is presented in an intelligible fashion and is written in standard English. The research meets all applicable standards for the ethics of experimentation and research integrity. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A Novel Approach to Predicting Exceptional Growth in Research PONE-D-20-13116R1 Dear Dr. Boyack, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Lutz Bornmann Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The raised concerns have been adequately addressed. The inaccurate use of the term classification has been remedied. The definitions of the time periods have been moved. Reviewer #2: I very much appreciate the detailed answers to the reviewers' comments and the changes made to the manuscript. For future analyses and manuscripts I would recommend to use also the concepts of medical test diagnostics (e.g. valid negative, valid positive, basis rate, ...), because they are well known even outside of medicine and help the reader to quickly evaluate a model, even if the figures are significant lower than in medical testing. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-13116R1 A Novel Approach to Predicting Exceptional Growth in Research Dear Dr. Boyack: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Lutz Bornmann Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .